Anatara Lifesciences Ltd (ASX:ANR)
Australia
· Delayed Price · Currency is AUD
0.0110
0.00 (0.00%)
Mar 6, 2026, 3:18 PM AEST
Anatara Lifesciences Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Net Income | -1.31 | -1.95 | -1.45 | -2.02 | -2.53 | -2 | |
| Depreciation & Amortization | 0 | 0 | 0 | 0.02 | 0.02 | 0.01 | |
| Stock-Based Compensation | 0.09 | 0.09 | 0.03 | 0.05 | 0.07 | 0.12 | |
| Other Operating Activities | 0.54 | 0.01 | 0.05 | 0.02 | 0 | 0 | |
| Change in Accounts Receivable | -0.36 | -0.36 | 0.33 | -0.5 | 0.26 | -0.14 | |
| Change in Accounts Payable | -0.04 | -0.04 | -0.23 | 0.17 | -0.03 | -0.08 | |
| Change in Other Net Operating Assets | -0.01 | -0.01 | 0.01 | -0.01 | -0.03 | -0.01 | |
| Operating Cash Flow | -1.09 | -2.27 | -1.25 | -2.26 | -2.23 | -2.1 | |
| Capital Expenditures | - | - | - | -0 | -0.01 | -0 | |
| Investment in Securities | 0.05 | - | 0.05 | - | -0.05 | - | |
| Investing Cash Flow | 0.05 | - | 0.05 | -0 | -0.06 | -0 | |
| Long-Term Debt Issued | - | 0.4 | - | - | - | - | |
| Long-Term Debt Repaid | - | - | - | -0.02 | -0.02 | -0 | |
| Net Debt Issued (Repaid) | -0.01 | 0.4 | - | -0.02 | -0.02 | -0 | |
| Issuance of Common Stock | 1.2 | 1.09 | 1.99 | 1.7 | - | 3.07 | |
| Repurchase of Common Stock | - | - | - | - | - | -0.04 | |
| Other Financing Activities | -0.12 | -0.1 | -0.16 | -0.19 | -0.01 | -0.18 | |
| Financing Cash Flow | 1.07 | 1.39 | 1.83 | 1.49 | -0.02 | 2.85 | |
| Net Cash Flow | 0.03 | -0.88 | 0.63 | -0.77 | -2.31 | 0.75 | |
| Free Cash Flow | -1.09 | -2.27 | -1.25 | -2.26 | -2.24 | -2.1 | |
| Free Cash Flow Margin | -174.82% | -234.36% | -193.69% | - | - | - | |
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.02 | -0.03 | -0.03 | |
| Levered Free Cash Flow | -0.61 | -1.6 | -0.74 | -1.53 | -1.27 | -1.39 | |
| Unlevered Free Cash Flow | -0.61 | -1.6 | -0.74 | -1.53 | -1.27 | -1.39 | |
| Change in Working Capital | -0.41 | -0.41 | 0.12 | -0.33 | 0.2 | -0.23 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.